Evidence map›Paper›PMID 33297331›Full record

ArticleInternational journal of molecular sciences2020

A Celecoxib Derivative Eradicates Antibiotic-Resistant

Shiou-Ru Tzeng, Yi-Wei Huang, Yao-Qing Zhang, Ching-Yi Yang, Han-Sheng Chien, Yi-Ru Chen, Sung-Liang Yu, Ching S Chen, Hao-Chieh Chiu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. The anti-inflammatory drug celecoxib is metabolized by Pseudomonas aeruginosa CYP107S1 in vitro and in vivo.Drug metabolism and disposition: the biological fate of chemicals · 2025
    Article
  2. Drug Repurposing: An Emerging Strategy inJournal of microbiology and biotechnology · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. UsingFrontiers in pharmacology · 2022
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shiou-Ru TzengInstitute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan.
Yi-Wei HuangDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei 10048, Taiwan.
Yao-Qing ZhangInstitute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan.
Ching-Yi YangDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei 10048, Taiwan.
Han-Sheng ChienDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei 10048, Taiwan.
Yi-Ru ChenDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei 10048, Taiwan.
Sung-Liang YuDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei 10048, Taiwan.
Ching S ChenDrug Development Center, China Medical University, Taichung 40402, Taiwan.
Hao-Chieh ChiuDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei 10048, Taiwan.ORCID 0000-0002-8800-8474
National Taiwan University · TWChina Medical University · TW

Funding

the Ministry of Science and Technology (MOST), Taiwan 103-2320-B-002-041-MY3; 104-2113-M-002- 016-MY2
6 · The paper itself

Abstract

The treatment of

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBinding SitesBiofilmsCelecoxibCyclooxygenase 2 InhibitorsEnzyme StabilityMembrane Transport ProteinsMethicillin-Resistant Staphylococcus aureusProtein BindingAnti-Bacterial AgentsBacterial ProteinsCelecoxibCyclooxygenase 2 InhibitorsMembrane Transport ProteinsMRSAsurface plasmon resonancethermal shifttranslocon

Identifiers

PMID33297331
PMCPMC7730571
OpenAlexW3110989189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.